Studies on New Acidic Azoles as Glucose-Lowering Agents in Obese, Diabetic db/db Mice

Journal of Medicinal Chemistry

Volumn 38, Issue 4, 1995, Pages 617-628

  Kees, Kenneth L ^a   Caggiano, Thomas J ^a   Steiner, Kurt E ^a   Fitzgerald, John J ^a   Kates, Michael J ^b   Christos, Thomas E ^c   Kulishoff, John M ^a   Moore, Robin D ^a   McCaleb, Michael L ^d  

^a PFIZER INC   (United States)

^b VILLANOVA UNIVERSITY   (United States)

^c DUPONT COMPANY   (United States)

^d BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ISOXAZOLE DERIVATIVE; PYRAZOLONE DERIVATIVE; PYRROLE DERIVATIVE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SYNTHESIS; GLUCOSE BLOOD LEVEL; MALE; MOUSE; NONHUMAN; OBESITY; ORAL DRUG ADMINISTRATION; PKA; STRUCTURE ACTIVITY RELATION;

ANIMAL; AZOLES; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIC AGENTS; MICE; MICE, INBRED C57BL; MICE, OBESE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029031374     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00004a008     Document Type: Article

References (70)

1. National Diabetes Data Group. In Diabetes in America; National Institutes of Health: Bethesda, MD, 1985.
2. Taylor, R.; Agius, L. Biochemistry of Diabetes. Biochem. J. 1988, 250, 625-640.
3. DeFronzo, R. A. The Triumvirate: β-Cell, Muscle, Liver. A Collision Responsible for NIDDM. Diabetes 1988, 37, 667-687.
4. Isley, W. L. Treatment of Non-Insulin-Dependent Diabetes Mellitus. Drugs Today 1990, 26, 59-72.
5. Horton, E. S. Exercise and Physical Training: Effects on Insulin Sensitivity and Glucose Metabolism. Diabetes/Metab. Rev. 1986, 2, 1-17.
6. Kennedy, D. L.; Piper, J. M.; Baum C. Trends in Use of Oral Hypoglycemic Agents: 1964-1986. Diabetes Care 1988, 11, 558-562.
7. Bilous, R. W.; Alberti, K. G. M. M. Insulin Treatment: Efficacy and Inadequacy and Campbell, I. W. Sulfonylureas and Metformin: Efficacy and Inadequacy. In New Antidiabetic Drugs; Bailey, C. J., Flatt, P. R., Eds.; Smith-Gordon/Nishimura: London, 1990; pp 19-51.
8. Goldman, J. M. Oral Hypoglycemic Agents: An Update of Sulfonylureas. Drugs Today 1989, 25, 689-695.
9. Stout, R. W. Overview of the Association between Insulin and Atherosclerosis. Metabolism 1985, 34 (suppl. 1), 7-12.
10. Stout, R. W. Insulin and Atheroma-An Update. Lancet 1987, No. 1, 1077-1079.
11. Steiner, K. E.; Lien, E. L. Hypoglycemic Agents Which Do Not Release Insulin. In Progress in Medicinal Chemistry; Ellis, G. P., West, C. B., Eds.; Elsevier: Oxford, 1987; Vol. 24, pp 209-248.
12. Colca, J. R.; Tanis, S. P. Recent Advances in the Discovery and Development of Potential Antidiabetic Agents. Annu. Rep. Med. Chem. 1992, 27, 219-213.
13. Shoda, T.; Mizuno, K.; Tawada, H.; Imamiya, E.; Sugiyama, Y.; Fujita, T.; Kawamatsu, Y. Studies on Antidiabetic Agents I. Synthesis of 5-[4-(2-Methyl-2-phenylpropoxy) benzyl]thiazolidine-2, 4-dione (AL-321) and Related Compounds and Studies on Antidiabetic Agents II. Synthesis of 5-[4-(l-methylcyclohexyl-methoxybenzyl]thiazolidine-2, 4-dione (ADD-3878) and Its’ Derivatives. Chem. Pharm. Bull. 1982, 30, 3563-3573, 3580-3616.
14. Fujita, T.; Sugiyama, Y.; Taketomi, S.; Sohda, T.; Kawamatsu, Y.; Iwatsuka, H.; Suzuoki, Z. Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4-(l-Methylcyclohexylmethoxy)-benzyl]thiazolidine-2, 4-dione (ADD-3878, U-63, 287, Ciglitazone), a New Antidiabetic Agent. Diabetes 1983, 32, 804-810.
15. Chang, A. Y.; Wyse, B. M.; Gilchrist, B. J.; Peterson, T.; Diani, A. R. Ciglitazone, a New Hypoglycemic Agent 1. Studies in ob/ob and db/db Mice, Diabetic Chinese Hamsters, and Normal and Streptozotocin-Diabetic Rats. Diabetes 1983, 32, 830.
16. Sohda, T.; Mizuno, K.; Marnose, Y.; Ikeda, H.; Fujita, T.; Meguro, K. Studies on Antidiabetic Agents. 11. Novel Thiazolidinedione Derivatives as Potent Hypoglycemic and Hypolipidemic Agents. J. Med. Chem. 1992, 35, 2617-2626.
17. Hulin, B.; Clark, D. A.; Goldstein, S. W.; McDermott, R. E.; Dambek, P. J.; Kappeler, W. H.; Lamphere, C. H.; Lewis, D. M.; Rizzi, J. P. Novel Thiazolidene-2, 4-diones as Potent Euglycemic Agents. J. Med. Chem. 1992, 35, 1853-1864.
18. Williams, D. G.; Deldar, A.; Jordan, W. H.; Gries, C.; Long, G. G.; Dimarchi, R. D. Subchronic Toxicity of the Thiazolidenedione, Tanabe 174, in Rat and Dog. Diabetes 1993, 42 (Suppl. 1), 59A (abstr. 186).
19. Deldar, A.; Williams, G.; Stevens, C. Pathogenesis of Thiazolidinedione Induced Hematotoxicity in the Dog. Diabetes 1993, 42 (suppl. 1), 57A (abstr. 179).
20. Meguro, K.; Fujita, T. US Patent 4, 687, 777, 1987.
21. Shoda, T.; Mizuno, K.; Tawada, H.; Imamiya, E.; Sugiyama, Y.; Fujita, T.; Kawamatsu, Y. Studies on Antidiabetic Agents I. Synthesis of 5-[4-(2-Methyl-2-phenylpropoxy) benzyl]thiazolidine-2, 4-dione (AL-321) and Related Compounds and Studies on Antidiabetic Agents II. Synthesis of 5-[4-(l-methylcyclohexylmethoxybenzyl]thiazolidine-2, 4-dione (ADD-3878) and Its’ Derivatives. Chem. Pharm. Bull. 1982, 30, 3563-3573, 3580-3616.
22. Sutter, S. L.; Nolan, J. J.; Wallace, P.; Gumbiner, B.; Olefsky, J. M. Metabolic Effects of New Hypoglycemic Agent CS-045 in NIDDM Subjects. Diabetes Care 1992, 15, 193-203.
23. Norris, R.; Valiquett, T.; Balagtas, C. Comparisons of Troglitazone (Cl 991) Dosing Regimens and Placebo in the Treatment of Patients with NIDDM. Diabetes 1993, 42 (suppl. 1), 59A (abstr. 187).
24. Kees, K. L.; Smith, T. M.; McCaleb, M. L.; Prozialeck, D. H.; Cheeseman, R. S.; Christos, T. E.; Patt, W. C.; Steiner, K. E. Perfluorocarbon-Based Antidiabetic Agents. J. Med. Chem. 1992, 35, 944-953.
25. Kees, K. L.; Cheeseman, R. S.; Prozialeck, D. H.; Steiner, K. E. Perfluoro-N-[4-(1H-tetrazol-5-ylmethyl)-phenyl]alkanamides: A New Class of Oral Antidiabetic Agents. J. Med. Chem. 1989, 32, 11-13.
26. Steiner, K. E.; McCaleb, M. L.; Kees, K. L. Perfluoro Anilides: New Tools for the Study of Insulin-Resistant States, In New Antidiabetic Drugs; Bailey, C. J., Flatt, P. R., Eds.; Smith-Gordon: London, 1990; pp 237-244.
27. Zask, A.; Jirkovsky, I.; Nowicki, J. W.; McCaleb, M. L. Synthesis and Antihyperglycemic Activity of Novel 5-(Naphthalenylsulfonyl)-2, 4-thiazolidinediones. J. Med. Chem., 1990, 33, 1418-1423.
28. Ellingboe, J. W.; Lombardo, L. J.; Alessi, T. R.; Nguyen, T. T.; Guzzo, F.; Guinosso, C. J.; Bullington, J.; Browne, E. N. C.; Bagli, J. F.; Wrenn, J.; Steiner, K.; McCaleb, M. L. Antihyperglycemic Activity of Novel Naphthalenyl-3H-1, 2, 3, 5-Oxathiadiazole-2-Oxides. J. Med. Chem. 1993, 36, 2485-2493.
29. Ellingboe, J. W.; Alessi, T. R.; Dolak, T. M.; Nguyen, T. T.; Tomer, J. D.; Guzzo, F.; Bagli, J. F.; McCaleb, M. L. Antihyperglycemic Activity of Novel Substituted 3H-1, 2, 3, 5-Oxathiadiazole-2-Oxides. J. Med. Chem. 1992, 35, 1176-1182.
30. Jacobsen, N.; Kolind-Andersen, H.; Christensen, J. Synthesis of 3-Isoxazolols Revisited. Diketene and β-Ketoesters as Starting Materials. Can. J. Chem. 1984, 62, 1940-1944.
31. Jacquier, R.; Petrus, C.; Petrus, F.; Verducci, J. Rechesrhes dans la Serie des. Azoles, LXXVI. Action de LTiydroxylamine sur les ß-Cetoesters: Synthese d’Isoxazolones-3 et 5. (Azoles. LXXVI. Reaction of hydroxylamine with ß-keto esters. Synthesis of 3- and 5-fsoxazolones.) Bull. Soc. Chim. Fr. 1970, 2685-2698.
32. Sato, M.; Ogasawara, H.; Komatsu, S.; Kato, T. Synthesis of ß-Ketocarboxamide Derivatives Using 2, 2, Dimethyl-2H, 4H-dioxin-4-ones. Chem. Pharm. Bull. 1984, 32, 3848-3856.
33. 13C NMR Study of the Reaction of β-Keto Esters with Hydroxylamine. J. Org. Chem. 1986, 51, 4037-4042.
34. Katritzky, A. R.; Karelson, M.; Harris, P. A. Prototropic Tautomerism of Heteroaromatic Compounds. Heterocycles 1991, 32, 329-369.
35. Katritzky, A. R.; Karelson, M.; Malhotra, N. Heterocyclic Aromaticity. Heterocycles 1991, 32, 127-161.
36. Jackson, W. R.; Zurqiyah, A. The occurrence of 1, 2 or 1, 4-Addition in the Reduction of some α, β-Unsaturated Ketones with Metal Hydrides. J. Chem. Soc. 1965, 5280-5287.
37. Mander, L. N.; Sethi, S. P. Regioselective Synthesis of β-Ketoesters from Lithium Enolates and Methyl Cyanoformate. Tetrahedron Lett. 1983, 24, 5425-5428.
38. Williams, H. W. R.; Eichler, E.; Randall, W. C.; Rooney, C. S.; Cragoe, E. J., Jr.; Streeter, K. B.; Schwam, H.; Michelson, S. R.; Patchett, A. A.; Taub D. Inhibitors of Glycolic Oxidase. 4-Sub-stituted 2, 4-Dioxobutanoic Acid Derivatives. J. Med. Chem. 1983, 26, 1196-1200.
39. Matsutani, S.; Hirai, K.; Tsutsumiuchi, M.; Mizui, T. 4-Oxoal-kanoic Acid Derivatives. JP 61, 134, 346, 1986.
40. Mayer, F.; Sieglitz, A.; Fischer, E.; Jung, R.; Knies, W.; Kohl, C.; Listmann, F.; Naugebauer, W.; Schulte, T. Investigations and ring closures in the series of methylnaphthalenes. Chem. Ber. 1922, 55B, 1835-1859.
41. Nakabayashi, T. Studies on Coumarin Derivatives 23. Stereoisomers of β-(1-Hydroxy-1, 2, 3, 4-tetrahydro-2-naphthyl) propionic Acid Lactones. Nippon Kagaku Zasshi 1960, 81, 121-124.
42. Nakabayashi, T. Chem. Abstr. 1962, 56, 1405e.
43. Begtrup, M.; Pedersen, C. Studies on Methylated 1, 2, 3-Triazoles. V. Preparation of 5-Substituted l-Alkyl-4-hydroxy-l, 2, 3-triazoles. Acta Chem. Scand. 1969, 23, 1091-1100.
44. Regitz, M.; Anschutz, W. Synthese von Diphenylphospinyl-diazomethanen durch Diazogruppen-Ubertragung. (Reactions of CH-active compounds with azides. XXV. Synthesis of diphenylphosphinyldiazomethanes by diazo group transfer.) Chem. Ber. 1969, 102, 2216-2229.
45. Begtrup, M.; Pedersen, C. Reaction of Phenyl Azide with Amides of Malonic acids and Phenylacetic Acid. Acta Chem. Scand. 1964, 18, 1333-1336.
46. Danheiser, R. L.; Miller, R. F.; Brisbois, R. G.; Park, S. Z. An Improved Method for the Synthesis of α-Diazo Ketones. J. Org. Chem. 1990, 55, 1959-1964.
47. Rooney, C. S.; Randall, W. C.; Streeter, K. B.; Ziegler, C.; Cragoe, E. J., Jr.; Schwam, H.; Michelson, S. R.; Williams, H. W. R.; Eichler, E.; Duggan, D. E.; Ulm, E. H.; Noll, R. M. Inhibitors of Glycolic Acid Oxidase. 4-Substituted 3-Hydroxy-1H-pyrrole-2, 5-dione Derivatives. J. Med. Chem. 1983, 26, 700-714.
48. Kuzma, P. C.; Brown, L. E.; Harris, T. M. Generation of the Dianion of N-(Trimethylsilyl) acetamide and Reaction of the Dianion with Electrophilic Reagents. J. Org. Chem. 1984, 49, 2015-2018.
49. Vandensavel, J.-M.; Smeto, G.; L’Abbe, G. Reactions of Azides with Isocyanates. Cycloadditions and Cycloreversions. J. Org. Chem. 1973, 38, 675-678.
50. Kikugua, Y.; Fu, L. U.; Sakamoto, T. A New Synthesis of Nitriles from N-Methoxy Imidoyl Bromides by Photolysis. Synth. Commun. 1993, 23, 1061-1069.
51. Witkowski, S.; Roszkowska, W.; Czerepko, K.; Worowski, K. Antifibrinolytic Properties of 5-(4-aminobutyl)-2, 4-diketothiazolidine hydrochloride. Acta Pol. Pharm. 1984, 41, 385-390.
52. Singh, H.; Chawla, A. S.; Kapoor, V. K.; Paul, D.; Malhotra, R. K. In Progress in Medicinal Chemistry, Ellis, G. P., West, G. B., Eds.; Elsevier/North Holland Biochemical Press: Amsterdam, 1980; Vol. 17, Chapter 4.
53. Burger, A. Isosterism and Bioisosterism in Drug Design. In Progr. Drug Res. /Arzneim-Forsch 1991, 37, 287-371.
54. Lipinski, C. A. Bioisosterism in Drug Design. Annu. Rep. Med. Chem. 1986, 21, 283-291.
55. a, Log P and Med Chem CLog P Fragment Values of Acidic Heterocyclic Potential Bioisosteres. Quant. Struct. Act. Relat. 1991, 10, 109-117.
56. Chenard, B. L.; Lipinski, C. A.; Dominy, B. W.; Mena, E. E.; Ronau, R. T.; Butterfield, G. C.; Marinovic, L. C.; Pagnozzi, M.; Butler, T. W.; Tsang, T. A Unified Approach to Systematic Isosteric Substitution for Acidic Groups and Application to NMDA Antagonists Related to 2-Amino-7-phosphonoheptanoate. J. Med. Chem. 1990, 33, 1077-1083.
57. Wells, P. R. In Progress in Physical Organic Chemistry, Cohen, S. G., Streitwieser, A., Taft, R. W., Eds.; Wiley: New York, 1968; Vol. 6, pp 111-145.
58. Dennis, M. J. Absorption Processes. In Comprehensive Medicinal Chemistry, Taylor, J. B., Ed.; Pergammon Press: Oxford, 1990; Vol. 5, pp 7-9.
59. Rekker, R. F. The Hydrophobic Fragmental Constant; Elsevier: Amsterdam, 1976; pp 89-92.
60. Dow, R. L.; Bechle, B. M.; Chou, T. T.; Clark, D. A.; Hulin, B.; Stevenson, R. W. Benzyloxazolidine-2, 4-diones as Potent Hypoglycemic Agents. J. Med. Chem. 1991, 34, 1538-1544.
61. Goldstein, S. W.; McDermott, R. E.; Gibbs, E. M.; Stevenson, R. W. Hydroxyurea Derivatives as Hypoglycemic Agents. J. Med. Chem. 1993, 36, 2238-2240.
62. Kees, K. L. 4-Arylmethyl-5-Alkyl-3H-Pyrazol-3-Ones. U. S. Patents, 5, 194, 434 and 5, 183, 825, 1993.
63. Kees, K. L. Trifluoromethyl Substituted 1H-Pyrazoles and Derivatives Thereof. U. S. Patent 5, 274, 111, 1993.
64. Kees, K. L. Process for Treating Hyperglycemia Using Trifluoromethyl Substituted 3H-Pyrazol-3-Ones. U. S. Patent 5, 264, 451, 1993.
65. DeSelms, R. D.; Greaves, R. J. Schleigh, W. R. Preparations of Some Substituted Quinoxalines and 1, 2, 3, 4-tetrahydroquinoxalines. J. Heterocycl. Chem. 1974, 11, 595-597.
66. Buchta, E.; Galster, H.; Luther, F. Experiments on the Synthesis of Steroids 5. 6-Methoxy-2-cyclopentyl and 6-Methoxy-2-(2-cyclopenten-1-yl)-3, 4-dihydro-1 (2H)-naphthalenone and a NewSyn-thesis of 2-(2-cyclopenten-1-yl)-3, 4-dihydro-1 (2H)-naphthalenone. Chem. Ber. 1949, 82, 126-131.
67. Ameniya, Y.; Terada, A.; Wachi, K.; Miyazawa, H.; Hatakeyama, N.; Matsuda, K.; Oshima, T. Synthesis and Thromboxane Synthetase Inhibitory Activity of Di-or Tetrahydrobenzo[b]-thiophenecarboxylic Acid Derivatives. J. Med. Chem. 1989, 1265-1272.
68. Wierenga, W.; Skulnick, H. I. General, Efficient One-Step Synthesis of β-ketoesters. J. Org. Chem. 1979, 49, 310-311.
69. Sempronj, A. Formation of Isomeric Phenylhydrazones in the Japp-Klingaraann Reaction. Gass. Chim. Ital. 1938, 68, 263-271.
70. Corinno, A.; Begue, J. P.; Charpentier-Morize, M.; Nee, G.; Langlois, B. General Method of Preparation of Trifluoromethyl Ketones. Part 1. Direct Alkylation of Ethyl Trifluoroacetoacetate. J. Fluorine Chem. 1989, 44, 361-376.